- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$3.57 BnMarket Estimate, 2026
$3.94 BnMarket Forecast, 2034
$8.76 BnCAGR, 2026–2034
10.5%Executive Summary: Asia Pacific Syringes Market
- Market Scope: Comprehensive Asia Pacific syringes market analysis covering usability types, material formats, device variations, regional country profiles, and adoption metrics.
- Market Valuation: Valued at USD 3.57 billion (2025), estimated at USD 3.94 billion (2026), and projected to reach USD 8.76 billion by 2034, registering a strong CAGR of 10.50% (2026–2034).
- Primary Growth Drivers: Rising incidences of chronic illnesses (diabetes, cancer), rapid expansion of the geriatric population, surging adoption of biologic and injectable drug portfolios, and increasing awareness of safety features. Key market restraints include high costs of specialized syringes, risks of needle-stick injuries, and intense market competition from alternative drug delivery systems.
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment (2025 Position) | Fastest-Growing Segment |
|---|---|---|
| By Usability | Disposable Syringes (dominates via widespread use in conventional and routine healthcare procedures) | Prefilled Syringes (expanding rapidly due to safety benefits, precision dosing, and biologics) |
| By Material | Plastic Syringes (holds major market share due to lightweight construction and cost-efficiency) | Glass Syringes (gaining traction via high compatibility with sensitive biologic formulations) |
| By Type | General Syringes (staple volume driver across regional hospitals and clinical settings) | Specialized Syringes - Insulin Segment (accelerating via high diabetes prevalence) |
| By Country | China (leads regional demand backed by population density, manufacturing infrastructure, and chronic diseases) | India (showcasing a promising CAGR driven by high urban diabetes rates and a growing elderly population) |
Major Market Players & Market Structure
Market Structure: Highly competitive medical device and packaging environment featuring global healthcare leaders competing on product innovation, safety mechanism integration, and extensive distribution networks.
Key Companies: Becton, Dickinson and Company, Terumo Corporation, Medtronic plc, Smiths Medical, B. Braun Medical Inc., NIPRO Corporation, Hindustan Syringes & Medical Devices Limited, Gerresheimer AG, SCHOTT AG, and CODAN Medizinische Geräte GmbH & Co KG.
Asia Pacific Syringes Market Size
The Asia Pacific Syringes Market size was valued at USD 3.57 billion in 2025 and is anticipated to reach USD 3.94 billion in 2026 from USD 8.76 billion by 2034, growing at a CAGR of 10.5% during the forecast period from 2026 to 2034.
Increase in the incidences of chronic diseases such as cancer, diabetes, and another disease. In this region, 60 percent of people who have diabetes demand more syringes to manage the treatment flow, which is estimated to accelerate the growth rate of the APAC syringes market primarily. China and India have the maximum prevalence of chronic disease due to the increasingly growing population in these countries. According to the world health organization, aging is increasing rapidly in the APAC region. It is estimated that the proportion of the elderly population is expected to grow from over 13.7 percent to 20.3 percent.
Also, the growing patient population with medication availability increases the demand for syringes, boosting the market growth during the forecast period. Furthermore, the increase in the adoption of injectable drugs, which is due to the rise in the use of biologics for treating various diseases and rising in the prevalence of patient compliance with its growing awareness about its safety and importance, is giving a positive impact on the market. Moreover, increase in the new advancements and innovations for new products such as prefilled syringes, disposable syringes, and many more with various benefits over others.
However, an increase in the high costs of specialized syringes, which cost over 1 to 3 dollars per syringe, and the pricing changes according to the brands and type of the syringe, is expected to hamper the market's growth rate slightly. Also, the rising cases of needle-stick injuries that may lead to infection of the diseases are the factors hindering the growth of the syringes market in the APAC region. In addition, increasing competition between the market players that are giving rise to the availability of various kinds of drug delivery methods present in the market is limiting the market growth.
Geographically, Asia-Pacific is expected to grow at the highest CAGR during the forecast period because of the growing healthcare facilities, and technological advancements in developing countries like India and China.
The major countries such as China, Japan, and Australia are expected to show significant growth during the forecast period with the increase in government and non-government initiatives and funding for research purposes will drive the market as well as an increase in the adopting rates for the injectables drugs with the rise in the competition between the market players.
The Indian Syringes market is anticipated to showcase a promising CAGR during the forecast period. As in India, due to the increase in chronic diseases with the rise in the geriatric population as in India more than 75 million people who are above 65 aged majorly suffer from chronic diseases such as diabetes. According to the report, it is estimated that 72.86 million adults in India suffer from this disease. The prevalence rate of this disease is maximum in urban areas than the rural areas; the prevalence ranges from 10.9 percent to 14.2 percent in urban areas.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| CAGR | 10.5% |
| Segments Covered | By Usability, Material, Type and Region |
| Various Analyses Covered | Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
| Countries Covered | India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, the Philippines, Indonesia, Singapore, and the Rest of APAC. |
| Market Leaders Profiled | Becton, Dickinson and Company, Terumo Corporation, Medtronic plc, Smiths Medical, B. Braun Medical Inc., NIPRO Corporation, Hindustan Syringes & Medical Devices Limited, Gerresheimer AG, SCHOTT AG, and CODAN Medizinische Geräte GmbH & Co KG. |
KEY MARKET PLAYERS
A few of the noteworthy companies operating in the APAC syringes market include
- Becton, Dickinson and Company
- Terumo Corporation
- Medtronic plc
- Smiths Medical
- B. Braun Medical Inc.
- NIPRO Corporation
- Hindustan Syringes & Medical Devices Limited
- Gerresheimer AG
- SCHOTT AG
- CODAN Medizinische Geräte GmbH & Co KG
MARKET SEGMENTATION
This research report on the Asia-Pacific syringes market has been segmented and sub-segmented into the following categories
By Usability
- Sterilizable/reusable
- Hypodermic
- Oral
- Disposable Syringes
- Conventional
- Safety
- Prefilled
By Material
- Glass Syringes
- Plastic Syringes
By Type
- General Syringes
- Specialized Syringes
- Insulin
- Tuberculin
- Allergy
- Others
By Country
- India
- China
- Japan
- South Korea
- Australia
- New Zealand
- Thailand
- Malaysia
- Vietnam
- Philippines
- Indonesia
- Singapore
- Rest of APAC